Back to Search Start Over

Effect of Heart Failure on Long‐Term Clinical Outcomes After Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With Severe Coronary Artery Disease

Authors :
Eiji Shinoda
Yoshiharu Soga
Yasuaki Takeji
Yoshihisa Nakagawa
Takeshi Morimoto
Kenji Ando
Yusuke Yoshikawa
Kazushige Kadota
Kazuhisa Kaneda
Naoki Kanemitsu
Yukihito Sato
Kenji Minatoya
Yutaka Furukawa
Ryuzo Nawada
Kazuaki Imada
Ko Yamamoto
Satoru Suwa
Tsukasa Inada
Hiroki Shiomi
Atsushi Iwakura
Ryoji Taniguchi
Tadaaki Koyama
Mamoru Toyofuku
Cabg Registry Cohort Investigators
Tatsuhiko Komiya
Takeshi Aoyama
Eri Kato
Takeshi Kimura
Kyohei Yamaji
Yukiko Matsumura-Nakano
Toshihiro Tamura
Natsuhiko Ehara
Mitsuo Matsuda
Tomohisa Tada
Takenori Domei
Masahiro Natsuaki
Fumio Yamazaki
Source :
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Publication Year :
2021
Publisher :
Ovid Technologies (Wolters Kluwer Health), 2021.

Abstract

Background Heart failure might be an important determinant in choosing coronary revascularization modalities. There was no previous study evaluating the effect of heart failure on long‐term clinical outcomes after percutaneous coronary intervention (PCI) relative to coronary artery bypass grafting (CABG). Methods and Results Among 14 867 consecutive patients undergoing first coronary revascularization with PCI or isolated CABG between January 2011 and December 2013 in the CREDO‐Kyoto PCI/CABG registry Cohort‐3, we identified the current study population of 3380 patients with three‐vessel or left main coronary artery disease, and compared clinical outcomes between PCI and CABG stratified by the subgroup based on the status of heart failure. There were 827 patients with heart failure (PCI: N=511, and CABG: N=316), and 2553 patients without heart failure (PCI: N=1619, and CABG: N=934). In patients with heart failure, the PCI group compared with the CABG group more often had advanced age, severe frailty, acute and severe heart failure, and elevated inflammatory markers. During a median 5.9 years of follow‐up, there was a significant interaction between heart failure and the mortality risk of PCI relative to CABG (interaction P =0.009), with excess mortality risk of PCI relative to CABG in patients with heart failure (HR, 1.75; 95% CI, 1.28–2.42; P P =0.77). Conclusions There was a significant interaction between heart failure and the mortality risk of PCI relative to CABG with excess risk in patients with heart failure and neutral risk in patients without heart failure.

Details

ISSN :
20479980
Volume :
10
Database :
OpenAIRE
Journal :
Journal of the American Heart Association
Accession number :
edsair.doi.dedup.....48f5ed1a71e7a715e6cf37cf6640ef99
Full Text :
https://doi.org/10.1161/jaha.121.021257